Cargando…
Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1
cis-Diamminedichloroplatinum (CDDP) is widely used for the treatment of various solid cancers. Here we reported that CDDP increased the expression and enzymatic activities of carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2), along with the upregulation of pregnane X receptor (PXR) and the dow...
Autores principales: | Xu, Minqin, Zhang, Lihua, Lin, Lan, Qiang, Zhiyi, Liu, Wei, Yang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687532/ https://www.ncbi.nlm.nih.gov/pubmed/37990879 http://dx.doi.org/10.7555/JBR.37.20230047 |
Ejemplares similares
-
Interleukin-6 Induces DEC1, Promotes DEC1 Interaction with RXRα and Suppresses the Expression of PXR, CAR and Their Target Genes
por: Ning, Rui, et al.
Publicado: (2017) -
Fluorine impairs carboxylesterase 1-mediated hydrolysis of T-2 toxin and increases its chondrocyte toxicity
por: Jia, Yumeng, et al.
Publicado: (2022) -
PXR as a mediator of herb–drug interaction
por: Hogle, Brett C., et al.
Publicado: (2017) -
The roles of carboxylesterase and CYP isozymes on the in vitro metabolism of T-2 toxin
por: Lin, Ni-Ni, et al.
Publicado: (2015) -
Human carboxylesterases: a comprehensive review
por: Wang, Dandan, et al.
Publicado: (2018)